NNVC
NANOVIRICIDES, INC.
Next earnings ≈ Aug 10, 2026 · est. from filing cadence
$1.34
▲ +3.08%$1.34▼ -6.29%
over 1Y
L $0.85EODHDH $2.03
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+3.1%
1W+1.5%
1M-23.4%
3M+47.3%
YTD+10.7%
1Y-6.3%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
Conservative balance sheet (liabilities/equity 0.17x).
NANOVIRICIDES, INC. shows $0.00 in FY2025 revenue, and -125.9% ROE.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $0.00 |
| Gross profit | — | — | — | — | — |
| Operating income | -$8.74M | -$8.11M | -$8.94M | -$8.52M | -$9.59M |
| Net income | -$8.82M | -$8.11M | -$8.59M | -$8.29M | -$9.47M |
| Diluted EPS | -$0.81 | -$0.70 | -$0.74 | -$0.70 | -$0.63 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$32.0M
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-40.5%
FCF yield-36.5%
Quality & risk
ROIC (est.)-42.8%
Free cash flow-$8.54M
Total debt$10.2M
Net cash-$8.65M
Altman Z-Score-16.37 distress
Piotroski F-Score1/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+18.8%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsSome governance/structural items recently, but no outright red flags.
- S-3 Shelf registration (potential raise)2026-06-15
- S-3 Shelf registration (potential raise)2026-06-05
- 8-K Reg FD disclosure2026-05-21
- 8-K Material agreement2026-05-20
- 10-Q Quarterly report2026-05-15
- 10-Q Quarterly report2026-02-17
- S-3 Shelf registration (potential raise)2025-12-15
- 8-K Shareholder vote2025-11-26
- 8-K Material agreement2025-11-14
Recent filings
all on EDGAR ↗DEL AMFiling2026-06-22open ↗DEL AMFiling2026-06-17open ↗EFFECTFiling2026-06-15open ↗S-3Filing2026-06-15open ↗S-3Filing2026-06-05open ↗8-KPeriod ending 2026-05-202026-05-21open ↗8-KPeriod ending 2026-05-152026-05-20open ↗424B5Filing2026-05-18open ↗10-QPeriod ending 2026-03-312026-05-15open ↗DFiling2026-02-25open ↗10-QPeriod ending 2025-12-312026-02-17open ↗424B3Filing2025-12-30open ↗
Frequently asked
- Is NANOVIRICIDES, INC. (NNVC) a buy?
- NNVC currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.17x).
- What is NANOVIRICIDES, INC.'s quality score?
- NNVC scores 36.179487179487175/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001379006, latest 10-Q filed 2026-05-15) · EODHD · as of 6/26/2026, 7:05:04 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.